CAR-T therapyin China

Your Care, Coordinated.

Northbridge curates bespoke CAR-T treatment journeys to China – taking care of every tiny concern or worry – so you can focus on getting better.

As covered by BBC World Service

Why cancer patients are flying to China for treatment

Book Consultation

Concierge support

Every step, quietly handled

Personal Coordinator

Travel, family logistics and hospital matching.

Interpreter

Every consultation, ward round and discharge conversation.

Vetted Hospitals

Licensed, accredited and approved treatment products.

Complete Discretion

Private contact channels and careful information handling.

What Northbridge does

A simpler way to reach advanced care.

From your first consultation to your return home, a single coordinator manages the hospital, the travel, the interpreter, and everything in between.

Your journey

Focus on healing, we'll take care of the rest.

Our coordinators will build an experience you are entirely comfortable with, and are there to support you every step of the way.

  1. Preliminary consultation

    Send records for private review before travel is discussed.

  2. Customise your plan

    See the proposed hospital, treatment route and full cost.

  3. Meet your coordinator

    A coordinator and interpreter stay with you through the journey.

  4. Flights and hotel selection

    Flights, transfers and a calm place to stay are arranged around care.

  5. Meet your English-speaking doctor

    Your physician reviews the plan with interpretation in the room.

  6. Begin treatment

    Treatment begins with your interpreter, coordinator and family support in place.

Blog

Read the wider CAR-T conversation.

Read the latest news and thought-leading articles on this groundbreaking new treatment.

BBC World Service

Why cancer patients are flying to China for treatment

The public conversation around CAR-T access, cost and medical travel in China.

Nature Reviews Drug Discovery

CAR T therapy for solid cancer scores first approval in China

A recent China approval shows how the CAR-T field is moving beyond blood cancers.

FDA

First CAR T-cell therapy for marginal zone lymphoma in the U.S.

New indications show how approved CAR-T use continues to expand in blood cancers.

Confidential first review

Your journey starts here.

Book your free, no-commitment consultation. We're ready to answer any questions you have.